Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Endocrine Disrupter Screening and Testing Advisory Committee.
Puberty in mammalian species is a period of rapid interactive endocrine and morphological changes. Therefore, it is not surprising that exposure to a variety of pharmaceutical and environmental compounds has been shown to dramatically alter pubertal development. This concern was recognized by the Endocrine Disrupter Screening and Testing Advisory Committee (EDSTAC) that acknowledged the need for the development and standardization of a protocol for the assessment of the impact of endocrine-disrupting compounds (EDC) in the pubertal male and recommended inclusion of an assay of this type as an alternative test in the EDSTAC tier one screen (EPA, 98). The pubertal male protocol was designed to detect alterations of pubertal development, thyroid function, and hypothalamic-pituitary-gonadal (HPG) system peripubertal maturation. In this protocol, intact 23-day-old weanling male rats are exposed to the test substance for 30 days during which pubertal indices are measured. After necropsy, reproductive and thyroid tissues are weighed and evaluated histologically and serum taken for hormone analysis. The purpose of this review was to examine the available literature on pubertal development in the male rat and evaluate the efficacy of the proposed protocol for identifying endocrine-disrupting chemicals. The existing data indicate that this assessment of puberty in the male rat is a simple and effective method to detect the EDC activity of pesticides and toxic substances.
Stoker
T E
TE
Gamete and Early Embryo Biology Branch, Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.
Parks
L G
LG
Gray
L E
LE
Cooper
R L
RL
D000818:Animals; D015386:Hazardous Substances / Q000633:toxicity*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008297:Male; D051381:Rats; D012741:Sexual Maturation / Q000187:drug effects* / Q000502:physiology; D013737:Testis / Q000187:drug effects / Q000254:growth & development / Q000378:metabolism; D013959:Thyroid Diseases / Q000139:chemically induced* / Q000473:pathology; D013961:Thyroid Gland / Q000187:drug effects* / Q000502:physiology; D018675:Toxicity Tests; D014481:United States; D014484:United States Environmental Protection Agency
D015386:Hazardous Substances